Latest Ratios: P/E Ratio 21.6x · EV/EBITDA 3.3x · ROE 19.8%. (2011–2025 historical series)
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Market Cap | $92M | $1.1B | $59M | $24M | $42M | $92M | $115M | $49M | $45M | $29M | $7M |
| Enterprise Value | $93M | $1.1B | $57M | $35M | $44M | $99M | $106M | $33M | $31M | $25M | $18M |
| P/E Ratio → | 21.60 | 29.20 | — | — | — | — | — | — | — | — | — |
| P/S Ratio | 0.76 | 9.20 | 0.53 | 0.20 | 0.31 | 0.66 | 1.09 | 0.76 | 0.88 | 0.90 | 0.30 |
| P/B Ratio | 13.78 | 18.62 | 1.19 | 0.57 | 0.42 | 0.94 | 1.14 | 1.15 | 1.15 | 1.42 | 1.03 |
| P/FCF | 3.86 | 46.60 | 3.12 | 6.19 | 4.52 | 33.18 | — | 9.70 | 7.70 | — | — |
| P/OCF | 3.21 | 38.80 | 2.86 | 1.54 | 2.01 | 6.89 | — | 6.44 | 6.54 | 102.03 | — |
P/E links to full P/E history page with 30-year chart
Enterprise-value multiples — capital-structure-neutral measures of total business value
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EV / Revenue | — | 9.21 | 0.52 | 0.30 | 0.32 | 0.71 | 1.00 | 0.51 | 0.60 | 0.78 | 0.73 |
| EV / EBITDA | 3.26 | 38.97 | 2.27 | — | 2.03 | 5.03 | 22.21 | 7.42 | 97.35 | — | — |
| EV / EBIT | 8.08 | 98.32 | 6.44 | — | 7.31 | 28.84 | — | 495.22 | — | — | — |
| EV / FCF | — | 46.65 | 3.03 | 9.15 | 4.69 | 35.90 | — | 6.56 | 5.28 | — | — |
Margins and return-on-capital ratios measuring operating efficiency
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 46.5% | 46.5% | 45.1% | 39.5% | 39.2% | 37.7% | 38.3% | 36.1% | 38.2% | 44.4% | 45.2% |
| Operating Margin | 9.5% | 9.5% | 8.2% | -40.2% | 4.8% | 2.5% | -7.9% | -0.7% | -5.0% | -14.2% | -32.3% |
| Net Profit Margin | 9.0% | 9.0% | 7.1% | -41.6% | 3.9% | 2.0% | -8.4% | -1.4% | -4.2% | -17.5% | -35.9% |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | 19.8% | 19.8% | 17.2% | -67.9% | 5.4% | 2.8% | -12.2% | -2.1% | -7.2% | -40.7% | -80.1% |
| ROA | 13.6% | 13.6% | 10.5% | -45.5% | 3.9% | 2.0% | -9.1% | -1.7% | -5.8% | -20.7% | -32.0% |
| ROIC | 15.9% | 15.9% | 13.5% | -45.2% | 4.8% | 2.7% | -10.4% | -1.2% | -9.3% | -20.1% | -36.5% |
| ROCE | 20.0% | 20.0% | 17.1% | -56.0% | 5.9% | 3.2% | -10.7% | -1.0% | -8.4% | -26.9% | -47.3% |
Solvency and debt-coverage ratios — lower is generally safer
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.07 | 0.07 | 0.07 | 0.35 | 0.14 | 0.17 | 0.11 | 0.10 | 0.01 | 0.01 | 1.99 |
| Debt / EBITDA | 0.15 | 0.15 | 0.14 | — | 0.64 | 0.85 | 2.41 | 0.92 | 1.59 | — | — |
| Net Debt / Equity | — | 0.02 | -0.03 | 0.27 | 0.01 | 0.08 | -0.09 | -0.37 | -0.36 | -0.20 | 1.50 |
| Net Debt / EBITDA | 0.04 | 0.04 | -0.07 | — | 0.07 | 0.38 | -1.99 | -3.55 | -44.50 | — | — |
| Debt / FCF | — | 0.05 | -0.09 | 2.96 | 0.16 | 2.72 | — | -3.14 | -2.42 | — | — |
| Interest Coverage | 39.32 | 39.32 | 9.90 | -40.07 | 14.85 | 7.58 | -16.85 | 0.17 | -5.54 | -3.15 | -11.61 |
Short-term solvency ratios and asset-utilisation metrics
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.05 | 1.05 | 1.27 | 1.00 | 1.55 | 1.20 | 1.54 | 2.77 | 3.20 | 2.07 | 0.53 |
| Quick Ratio | 1.03 | 1.03 | 1.24 | 0.98 | 1.53 | 1.19 | 1.53 | 2.73 | 3.14 | 1.91 | 0.53 |
| Cash Ratio | 0.13 | 0.13 | 0.26 | 0.14 | 0.55 | 0.32 | 0.72 | 1.79 | 1.77 | 1.01 | 0.22 |
| Asset Turnover | — | 1.38 | 1.55 | 1.50 | 1.02 | 0.99 | 0.76 | 1.14 | 1.06 | 1.25 | 0.86 |
| Inventory Turnover | 127.13 | 127.13 | 106.00 | 152.29 | 221.61 | 172.80 | 162.46 | 83.88 | 70.32 | 26.67 | — |
| Days Sales Outstanding | — | 56.72 | 56.39 | 53.00 | 50.41 | 56.82 | 56.23 | 53.20 | 71.78 | 44.51 | 64.54 |
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Yield | 0.8% | 0.6% | — | 60.0% | 36.1% | 15.7% | 9.9% | 12.4% | 9.2% | 5.2% | 9.7% |
| Payout Ratio | — | — | — | — | — | — | — | — | — | — | — |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Yield | 4.6% | 3.4% | — | — | — | — | — | — | — | — | — |
| FCF Yield | 25.9% | 2.1% | 32.1% | 16.2% | 22.1% | 3.0% | — | 10.3% | 13.0% | — | — |
| Buyback Yield | 0.0% | 0.0% | 1.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.7% | 0.0% | 7.5% |
| Total Shareholder Yield | 0.8% | 0.6% | 1.0% | 60.0% | 36.1% | 15.7% | 9.9% | 12.4% | 10.0% | 5.2% | 17.3% |
| Shares Outstanding | — | $380M | $16M | $16M | $15M | $15M | $13M | $12M | $12M | $11M | $10M |
Thin liquidity and volatility
Based on reported figures, CareCloud's forward P/E of 12.29 and EV/EBITDA of 3.25 suggest the market is pricing in significant execution risk, likely discounting the firm relative to higher-growth healthcare IT peers due to its inconsistent organic expansion and reliance on service-heavy revenue streams.
The valuation gap between the TTM P/E of 21.50 and the forward multiple indicates that investors are anticipating a sharp improvement in earnings, which may be overly optimistic given the historical volatility in net margins. The low EV/EBITDA multiple appears to reflect a market skepticism regarding the sustainability of the company's current profitability levels.
As reported in financial statements, CareCloud's ROIC has struggled to maintain positive momentum, fluctuating from a peak of 5.4% in 2024Q4 to a low of 1.3% in 2026Q1, which suggests that the company is failing to compound capital effectively within its current operational framework.
The persistent gap between invested capital and returns indicates that the company's roll-up strategy has yet to yield the expected synergies. Investors should monitor whether the firm can improve its asset utilization, as current returns remain insufficient to justify the capital intensity of its integrated platform.
According to recent quarterly data, CareCloud's cash conversion cycle has oscillated between 25 and 34 days, reflecting the inherent difficulty in managing a hybrid model that balances software subscription billing with the more complex, service-intensive revenue cycle management collections process.
The variability in DSO, which reached 60 days in 2025Q2, suggests that the company may face challenges in timely collections from its medical practice clients. This inefficiency in working capital management places additional pressure on the firm's already thin liquidity position.
Based on the provided balance sheet data, CareCloud's current ratio of 1.11 as of 2026Q1 highlights a precarious liquidity position that leaves little room for error, especially given the company's ongoing need to fund its offshore-heavy service delivery model and potential integration costs.
The proximity of the quick ratio to 1.00 suggests that the company is highly dependent on the immediate conversion of receivables to meet its short-term obligations. Any disruption in client payment cycles could force the company to seek external financing, potentially leading to further shareholder dilution.
Investors frequently misapply pure-play SaaS valuation multiples to CareCloud, failing to account for the high service-intensity of its RCM segment, which fundamentally limits gross margin expansion and necessitates a more nuanced approach to evaluating the company's true earning power.
Using standard SaaS metrics obscures the reality that a significant portion of the company's revenue is tied to variable labor costs rather than high-margin software licensing. Analysts should instead focus on contribution margins per client and the efficiency of the offshore labor force to better gauge the company's underlying profitability.
Includes 30+ ratios · 15 years · Updated daily
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
See how regular investing compounds over time.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying CCLD stock.
CareCloud, Inc.'s current P/E ratio is 21.6x. The historical average is 29.2x.
CareCloud, Inc.'s current EV/EBITDA is 3.3x. This enterprise value multiple compares the company's total value (equity + debt - cash) to its EBITDA. The historical average is 32.3x.
CareCloud, Inc.'s return on equity (ROE) is 19.8%. The historical average is -11.1%.
Based on historical data, CareCloud, Inc. is trading at a P/E of 21.6x. Compare with industry peers and growth rates for a complete picture.
CareCloud, Inc.'s current dividend yield is 0.77%.
CareCloud, Inc. has 46.5% gross margin and 9.5% operating margin.
CareCloud, Inc.'s Debt/EBITDA ratio is 0.2x, indicating low leverage. A ratio below 2x is generally considered financially healthy.